Two weeks after publishing an opinion piece that called for increased 340B program oversight and provider transparency, JAMA issued a [...] …
Articles by : Bella Czajkowski, National Correspondent
The Health Resources and Services Administration (HRSA) has requested public comment on how petitioners file their initial claims in the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) held a webinar yesterday to guide hospitals through their annual 340B recertification period, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent opinion piece published in JAMA is calling for significant reforms to the 340B program, including more provider transparency, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...] …